Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
787.00    11.50 (1.48%)
Bid:
789.50
Ask:
791.50
Spread: 2.00 (0.253%)
Market Cap: £906.42m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

16 Apr 2018 07:25

RNS Number : 9326K
Kainos Group plc
16 April 2018
 

16 April 2018

 

Kainos Group plc

("Kainos" or "the Company")

Trading Update

 

Kainos Group plc, a leading provider of Digital Services and Platforms, today issues a trading update for the year ended 31 March 2018. Trading in the period has continued in line with market expectations and the Company remains well positioned in its core markets.

Growth in Digital Services has been particularly strong, driven by both Digital Transformation and Workday, and with continued momentum across government and healthcare clients. Our international client base has also continued to expand, supported by the Group's broadened European footprint and growing reputation in the commercial sector following sales investment. A very strong sales performance has generated a comparable increase in contracted backlog.

Digital Platforms has performed in line with expectations, mainly driven by the Kainos Smart platform, where we have continued to acquire new clients successfully. The constrained funding in the UK NHS continues to impact short term growth of the Kainos Evolve platforms, although sales activity levels are showing signs of improvement that are consistent with our expectations.

Kainos has a robust balance sheet with no debt and strong cash generation. The Company has a growing level of recurring revenue and has a solid pipeline.

Recruitment remains strong, with over 194 people joining Kainos since 1 April 2017, bringing the total number of employees and contractors worldwide to 1,169 at the end of March 2018.

Kainos will announce results for the year ended 31 March 2018 on Tuesday 29 May 2018.

 

- ENDS-

For further information, please contact:

Kainos

via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Peter McKeown, Deputy Chief Financial Officer

Investec Bank plc 

+44 20 7597 4000

Patrick Robb / Sebastian Lawrence

Canaccord Genuity

+44 20 7523 4606

Simon Bridges / Emma Gabriel

FTI Consulting LLP

+44 20 3727 1000

Matt Dixon / Harry Staight

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the largest boutique partner for Workday Inc. ('Workday') in Europe, responsible for implementing Workday's innovative Software- as-a-Service (SaaS) platform for enterprise customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos employs approximately 1,200 staff and contractors across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms businesses.

Kainos is listed on the London Stock Exchange (KNOS). For further information, please visit www.kainos.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIJMATMBIBBJP
Date   Source Headline
8th Mar 20161:38 pmRNSDirector/PDMR Shareholding
1st Mar 201610:00 amRNSDirector/PDMR Shareholding
11th Feb 20166:09 pmRNSDirector/PDMR Shareholding
1st Feb 20167:00 amRNSInvestment in Cirdan Imaging Limited
27th Jan 201611:32 amRNSDirector/PDMR Shareholding
29th Dec 20152:59 pmRNSDirector/PDMR Shareholding
23rd Dec 201511:06 amRNSTransfer of Shares
21st Dec 201510:00 amRNSDisposal of investment in SpeechStorm Limited
18th Dec 20152:42 pmRNSDirector/PDMR Shareholding
17th Dec 20154:46 pmRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim Results
30th Sep 201512:27 pmRNSDirector/PDMR Shareholding
15th Sep 20155:54 pmRNSDirector/PDMR Shareholding
9th Sep 20155:27 pmRNSDirector/PDMR Shareholding
7th Sep 20159:00 amRNSNotice of Results
25th Aug 20158:00 amRNSNew Mobile-Enabled healthcare platform
24th Aug 20155:31 pmRNSDirector/PDMR Shareholding
6th Aug 20157:00 amRNSHolding(s) in Company
16th Jul 20159:05 amRNSDirector/PDMR Shareholding
10th Jul 20157:00 amRNSAdmission to trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.